Section Arrow
Quote
CDIO.NASDAQ
- Cardio Diagnostics Holdings Inc.
Quotes are at least 15-min delayed:2026/01/02 04:49 EST
Pre Market
Last
 2.64
-0.07 (-2.58%)
Bid
2.55
Ask
3
High 2.72 
Low 2.64 
Volume 39 
Regular Hours (Closed)
Last
 2.71
-0.47 (-14.78%)
Day High 
3.07 
Prev. Close
3.18 
1-M High
4.28 
Volume 
54.13K 
Bid
2.55
Ask
3
Day Low
2.6412 
Open
3.07 
1-M Low
2.8001 
Market Cap 
5.81M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.19 
20-SMA 3.29 
50-SMA 3.46 
52-W High 30.6 
52-W Low 2.4237 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-11.91/--
Enterprise Value
6.23M
Balance Sheet
Book Value Per Share
4.46
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
901
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4167+0.0462+12.47%-- 
Pre Market 0.444 +0.0273 +6.55%
OTLKOutlook Therapeutics1.58-0.285-15.28%0.58PE
Pre Market 0.67 -0.91 -57.59%
VNDAVanda Pharmaceuticals8.82+1.79+25.46%126.25PE
Pre Market 8.86 +0.04 +0.45%
SLSSELLAS Life Sciences Group3.77+0.46+13.90%-- 
Pre Market 4.135 +0.365 +9.68%
FBLGFibroBiologics0.2249-0.017-7.03%-- 
Pre Market 0.2282 +0.0033 +1.47%
Industry overview quotes are at least 15 minutes delayed
Business Description
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluatedby these tests to the drivers of coronary heart disease.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.